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Abstract The AMP-activated protein kinase (AMPK) is a 
heterotrimeric complex composed of a catalytic subunit (CL) and 
two regulatory subunits (p and r). Two isoforms of the catalytic 
subunit (czl and cz2) have been identified. We show here that the 
al- and c&containing complexes contribute approximately 
equally to total AMPK activity in rat liver. Furthermore, 
expression of al or a2 with p and y in mammalian cells 
demonstrates that both complexes have equal specific activity 
measured with the SAMS peptide. Using variant peptides, 
however, we show that al and a2 exhibit slightly different 
substrate preferences, which suggest that the two isoforms could 
play different physiological roles within the cell. 
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1. Introduction 
The AMP-activated protein kinase (AMPK) plays a role in 
the cellular response to environmental stresses which deplete 
ATP [1,2]. AMPK, a heterotrimeric enzyme composed of a 
catalytic subunit (a) and two regulatory subunits (0 and r) 
[3,4], is activated by AMP via a number of independent mech- 
anisms [5,6]. The a subunit is phosphorylated by an upstream 
protein kinase (AMPKK) resulting in greater than 50-fold 
activation of the AMPK complex [7]. Proteins related to all 
three subunits have been identified in the yeast SNFl kinase 
complex [3,4,8,9] which is involved in derepression of glucose- 
repressed genes [lO,l 11. Plant cDNAs encoding proteins re- 
lated to the catalytic subunit of AMPK and Snflp have also 
been isolated [8,12]. It appears therefore that the AMPK- 
related protein kinase family is widely distributed and that 
they have been highly conserved throughout evolution. 
A second form of AMPKa, encoded by a separate gene, 
has been identified recently [13]. It was reported that this iso- 
form, which the authors termed al, accounted for greater 
than 90% of AMPK activity present in rat liver measured 
using the SAMS peptide, whereas the a2 isoform, although 
present, accounted for less than 10% of the activity. 
We have re-examined the activities of the al- and a2-con- 
taining complexes in rat liver and find that each isoform con- 
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tributes approximately equally to AMPK activity. Further- 
more, expression of al- or aZcontaining complexes in a 
heterologous system resulted in similar levels of AMPK activ- 
ity. Using a panel of synthetic peptides [14], we show quanti- 
tative differences in rates of phosphorylation by al and a2. 
These results imply that both isoforms are equally important 
in the AMPK response in rat liver, but that their specificity 
for downstream targets within the cell could differ. 
2. Materials and methods 
AMPK was purified from rat liver as previously described [15]. 
AMPKa antibodies were raised in sheep against isoform-specific pep- 
tides derived from the deduced amino acid sequences of al 
(TSPPDSFLDDHHLTR) or a2 (MDDSAMHIPPGLKPH). Peptides 
were synthesised with a cysteine residue at the N-terminus, coupled to 
keyhole limpet haemocyanin and used for immunisation. Antibodies 
were affinity purified from serum using the appropriate peptide con- 
jugated to thiol-Sepharose [16]. Production of p and y antibodies have 
been described elsewhere [4]. Protein G-Sepharose was from Sigma, 
protein G and protein A conjugated with horseradish peroxidase were 
from Bio-Rad. CCL13 cells were obtained from The American Type 
Culture Collection. 
2.1. Immunoprecipitation of AMPK al and CL2 from rat liver 
Partially purified AMPK was incubated with excess al or a2 affin- 
ity purified antibody for 1 h at 4°C. 50 ~1 of protein G-Sepharose 
slurry in buffer A (50%, v/v) was added and the mixture incubated for 
a further 1 h at 4°C. After centrifugation the supematant was re- 
moved and an aliquot used to determine AMPK activity. The super- 
natant was subjected to a further immunoprecipitation using either 
the same antibody or an antibody to the other a isoform. The im- 
mune complexes were washed extensively with buffer and then ana- 
lysed for AMPK activity and by Western blotting. 
2.2. Western blots 
Samples were resolved by SDS-PAGE and transferred to polyvinyl- 
idene fluoride membrane. The membrane was blocked by incubation 
in 10 mM Tris-HCl, pH 7.4, 0.5 M NaCl, 0.5% Tween 20, 5% low fat 
milk powder for 1 h at room temperature. The primary antibody was 
applied in the same buffer and the blot incubated for between l-12 h 
at 4°C. After extensive washing with 10 mM Tris-HCl, pH 7.4, 0.5 M 
NaCl, 0.5% Tween 20, the blots were incubated for 1 h at room 
temperature with either protein A conjugated with horseradish perox- 
idase (for primary antibodies raised in rabbits) or protein G conju- 
gated with horseradish peroxidase (for sheep antibodies). After further 
extensive washing the blots were developed using enhanced chemilu- 
minescence (Boehringer Mannheim). 
2.3. Expression of AMPK subunits in CCL13 ceils 
cDNAs encoding each AMPK subunit were constructed in 
pcDNA3 (Invitrogen). CCL13 cells were transfected with plasmid 
DNA (10 pg of each plasmid) by calcium phosphate precipitation 
[17]. The precipitate was incubated with the cells overnight, followed 
by a 2 min incubation with phosphate-buffered saline containing 10% 
(v/v) dimethylsulphoxide. Cells were harvested 48 h post-transfection 
and lysed by resuspension in 50 mM Tris-HCl, 50 mM NaF. 5 mM 
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Fig. 1. AMPK, purified up to the gel filtration step, was immunoprecipitated using an excess of either al or a2 specific antibodies bound to 
protein G-Sepharose. A further addition of al antibody was added to the supernatant from the ct2 immunoprecipitation and vice versa. Sheep 
anti-rabbit IgG bound to protein G-Sepharose was used in control immunoprecipitations. A: AMPK activity remaining in the supernatant after 
each precipitation, presented as a percentage of the activity remaining in the control. The results shown are the means of four independent ex- 
perimentsIf.S.E.M. B: AMPK activity present in the immune complex from one of the above experiments is shown. A Western blot of each 
immune complex following SDS-PAGE analysis, probed with either al, a2 or y antibodies is shown in C. D: Western blot of the AMP and 
ATP eluates of AMPK following purification by chromatography on ATP-y-Sepharose, probed with either al or a2 antibodies. 
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sodium pyrophosphate, 1 mM EDTA, 1 mM dithiothreitol, 0.1 mM 
phenylmethylsulphonyl fluoride, 10% (v/v) glycerol, 1% Triton-X100 
(buffer A). Insoluble material was removed by centrifugation and the 
supernatant made to 10% (w/v) with polyethylene glycol. After 10 min 
on ice the precipitate was collected by centrifugation and resuspended 
in buffer A. 
2.4. AMPK assay 
AMPK activity was measured by phosphorylation of the SAMS 
peptide as previously described [18]. Activities in the immune com- 
plexes were measured by addition of the assay reagents directly to the 
immunoprecipitate. Just prior to removal of an aliquot (20 ul) from 
the reaction the mixture was centrifuged to pellet the immune com- 
plex. Assays to determine peptide specificity were performed at 
a single concentration of peptide (40 uM) as described elsewhere 
1141. 
3. Results 
3.1. Measurement of AMPK al and a2 activities in rat liver 
Antibodies specific to either al or a2, or sheep anti-rabbit 
IgG as a control, were used to immunoprecipitate AMPK 
from a partially purified preparation from rat liver. The 
amount of antibody used had been previously determined to 
be in excess. Activity remaining in the supernatant after pre- 
cipitation with anti-al antibody was 30-50% of the activity in 
the control (Fig. 1A). Alternatively, 52-57% of activity re- 
mained in the supernatant after immunoprecipitation with 
anti-a2 antibody. A second immunoprecipitation using the 
same antibody did not result in any further decrease in activ- 
ity in the supernatant (data not shown). Conversely, when the 
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Fig. 2. AMPK activity in a partially purified fraction of CCL13 
cells following transient transfection with cDNAs encoding Cal, p 
and y or 1x2, p and y is shown in A. In B, a Western blot of the 
AMPK subunits, after separation by SDS-PAGE, is shown. 
supernatant from the al precipitation was followed by immu- 
noprecipitation using a2 antibodies the activity remaining in 
the supernatant was reduced to O-5% of the activity in the 
control. Similarly, when a2 precipitation was followed by im- 
munoprecipitation using al antibodies the activity remaining 
in the supematant was reduced to O-6%. AMPK activity de- 
termined in the immune complex is shown in Fig. 1B. The 
activity in the immunoprecipitate due to each isoform specific 
antibody is the same whether it is measured preceding or 
following precipitation with the alternative antibody. The ac- 
tivity measured in the immune complex following precipita- 
tion using a2 antibody appeared to be significantly less than 
that using al antibody. The most likely explanation for this is 
349 
that binding of the a2 antibody interferes with kinase activity. 
To ensure that each antibody was specific for the isoform to 
which it was raised immunoblots of the immune complexes 
were probed with both al and a2 antibodies (Fig. 1C). The 
results show that only al, and not a2, is precipitated by anti- 
al antibody and that a2, and not al, is precipitated by anti- 
a2 antibody. These results also demonstrate that al and a2 
do not associate into a heterodimer. The blots were also 
probed with anti-y antibody which showed that a similar 
amount of y is associated with either al or a2. Neither al, 
a2 or y were precipitated by the control antibody and no 
activity could be detected in the control immune complex. 
The relative contribution of each a isoform to the total 
AMPK activity remains similar throughout different stages 
of purification (data not shown). Furthermore, al and a2 
co-purify throughout purification up to and including chro- 
matography on ATP-y-Sepharose. Fig. ID shows a Western 
blot of the AMP and ATP eluates following chromatography 
on ATP-y-Sepharose probed with either al or a2 antibody. 
3.2. Expression of AMPK in CCL13 cells 
cDNAs encoding al, a2, p or y were constructed in a 
mammalian expression vector under the control of the human 
cytomegalovirus promoter. al or a2 along with B and y were 
co-transfected into CCL13 cells. AMPK activity in a partially 
purified preparation of either untransfected or transiently 
transfected CCL13 cells was measured 48 h post-transfection 
and is shown in Fig. 2A. AMPK activity in transfected cells 
was at least IO-fold higher than the endogenous activity meas- 
ured in untransfected cells. Co-transfection of either al or a2 
with B and y resulted in expression of virtually indistinguish- 
able activities. Fig. 2B shows a Western blot of the partially 
purified extracts probed with subunit-specific antibodies. En- 
dogenous AMPK in untransfected cells was below the level of 
detection, whereas all three subunits were readily detectable in 
transfected cells. Co-transfection of all three subunits was 
necessary to detect expression of either a, p or y protein. 
Similarly, no significant increase in AMPK activity was ob- 
served when subunits were expressed either in isolation or in 
pair-wise combinations (data not shown). 
3.3. Substrate spectjicity of al and a2 
In order to demonstrate whether al and a2 recognise dif- 
ferent sequence motifs for phosphorylation, we used a panel 
of peptides which have been used previously to study the 
specificity of AMPK and related protein kinases [14]. Fig. 3 
shows the relative velocities measured using al or a2, pre- 
pared by specific immunodepletion of a purified preparation 
from rat liver which contained both isoforms. There were 
small differences in specificity between the two isoforms, par- 
ticularly with respect to the preference for hydrophobic side 
chain at the P-5 and P+4 position. Similar differences were 
obtained by assaying al or a2 in the immunoprecipitates, or 
by assaying recombinant al/Py or a2/By expressed in CCL13 
cells (not shown). 
4. Discussion 
We have shown that AMPK al and a2 co-purify through- 
out purification and that the relative contribution of each 
isoform to total activity in rat liver is approximately equal. 
This is in contrast to the results of a recent paper [13] report- 
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Fig. 3. Initial rate of phosphorylation of synthetic peptides, expressed relative to the rate obtained with the parent peptide AMARAASAAA- 
LARRR. Results for a2 (hatched bars) were obtained by immunoprecipitating al from AMPK purified to the gel filtration step, and vice versa 
for al (open bars). Western blots of the supernatants confirmed that they contained only al or a2. Results are the mean + S.E.M. for three de- 
terminations. The phosphorylated residue in the peptide is indicated by underlining and bold type, hydrophobic residues by bold type, and ba- 
sic residues by underlining. 
t 
ing that although both isoforms were present, as judged by 
Western blotting, the a2 isoform accounted for less than lo%, 
and the al isoform for greater than 90%, of the activity in rat 
liver. Our results are based on immunoprecipitation of 
AMPK activity using antibodies specific for either al or ~2. 
These results confirm previous data in which we used an anti- 
body raised against an a2 specific peptide which depleted 
activity by 40% [8]. Although the full details of the purifica- 
tion procedure used by Stapleton et al. have not been pre- 
sented as yet, we consider that the most likely explanation for 
the discrepancy between the two studies is that their purifica- 
tion protocol results in loss in activity of the a2 isoform. In 
addition to the finding that al and a2 contribute similarly to 
AMPK activity in tissue extracts, nearly identical activities 
were detected in cells expressing recombinant AMPK, regard- 
less of which a isoform was used for transfection. It is note- 
worthy that co-transfection of all three subunits is required in 
order to detect either expressed protein or activity. When only 
one or two subunits were transfected neither expressed protein 
nor activity could be detected. This suggests that either the 
mRNAs or, more likely the polypeptides, are unstable unless 
all three subunits are co-expressed in this system. Immunopre- 
cipitation of AMPK using al antibodies does not co-precipi- 
tate a2 and vice versa (Fig. lC), indicating that al and a2 are 
not associated into a heterodimer form. 
Both al and a2 have been shown to bind B and yin a 1: 1: 1 
ratio [ 13,151. Western blotting of the immunoprecipitates from 
rat liver indicate that very similar amounts of y co-precipitate 
with each a isoform. This suggests that the expression of al- 
and a2-containing complexes in rat liver is similar. Since al 
and a2 contribute roughly equally to AMPK activity this 
suggests that both isoforms have similar specific activities. 
The amino acid sequences of al and a2 are 77% identical 
[ 131. The major regulatory phosphorylation site within the a 
subunit has been mapped to threonine-172 [7] and the se- 
quence surrounding this site is identical in both isoforms. In 
addition both isoforms are stimulated to the same extent by 
AMP, and are both widely expressed in rat tissues [ 131. These 
similarities raise the question as to whether there is any dif- 
ference in the role of the isoforms within the cell. One possible 
functional difference between the two is their substrate specif- 
icity. In order to address this possibility we investigated the 
phosphorylation of a panel of synthetic peptides, which had 
been used previously to determine the phosphorylation recog- 
nition motif of what we now know to have been a mixture of 
al and a2 [14]. The results for each isoform were qualitatively 
similar to those obtained previously with the mixture. Both 
isoforms recognise the $(X,B)XXS/TXXX$ motif (where o 
represents a hydrophobic residue and p a basic residue) but 
there are quantitative differences with respect to preference for 
the hydrophobic residues at the P-5 and P+4 positions. Rel- 
ative to al, a2 appears to prefer leucine and isoleucine over 
methionine at the P-5 position and it also appears to prefer 
isoleucine over leucine at P+4. al also seems to be more 
tolerant of the basic residue being at the P-4 rather than 
P-3 position. These differences, although subtle, indicate 
that within the cell al and a2 could phosphorylate different 
substrates, at different rates, allowing more flexibility in the 
phosphorylation of downstream targets within the AMPK 
cascade. Further studies are necessary to elucidate the exact 
roles of both isoforms in vivo. 
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